Switch to:

Intra-Cellular Therapies Total Assets

: $440.93 Mil (As of Jun. 2020)
View and export this data going back to 2013. Start your Free Trial

Intra-Cellular Therapies's Total Assets for the quarter that ended in Jun. 2020 was $440.93 Mil.

During the past 12 months, Intra-Cellular Therapies's average Total Assets Growth Rate was 35.00% per year. During the past 3 years, the average Total Assets Growth Rate was 78.20% per year. During the past 5 years, the average Total Assets Growth Rate was 54.60% per year.

During the past 8 years, Intra-Cellular Therapies's highest 3-Year average Total Assets Growth Rate was 78.20%. The lowest was 2.80%. And the median was 69.60%.

Total Assets is connected with ROA %. Intra-Cellular Therapies's annualized ROA % for the quarter that ended in Jun. 2020 was -55.27%. Total Assets is also linked to Revenue through Asset Turnover. Intra-Cellular Therapies's Asset Turnover for the quarter that ended in Jun. 2020 was 0.00.


Intra-Cellular Therapies Total Assets Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Intra-Cellular Therapies Annual Data
Dec12 Mar13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Total Assets Premium Member Only Premium Member Only Premium Member Only 484.10 388.90 471.49 357.21 251.19

Intra-Cellular Therapies Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Total Assets Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 309.86 280.52 251.19 481.24 440.93

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Intra-Cellular Therapies Total Assets Distribution

* The bar in red indicates where Intra-Cellular Therapies's Total Assets falls into.



Intra-Cellular Therapies Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Intra-Cellular Therapies's Total Assets for the fiscal year that ended in Dec. 2019 is calculated as

Total Assets=Total Equity (A: Dec. 2019 )+Total Liabilities (A: Dec. 2019 )
=195.007+56.179
=251.19

Intra-Cellular Therapies's Total Assets for the quarter that ended in Jun. 2020 is calculated as

Total Assets=Total Equity (Q: Jun. 2020 )+Total Liabilities (Q: Jun. 2020 )
=379.53+61.401
=440.93

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Intra-Cellular Therapies  (NAS:ITCI) Total Assets Explanation

Total Assets is connected with ROA %.

Intra-Cellular Therapies's annualized ROA % for the quarter that ended in Jun. 2020 is

ROA %=Net Income (Q: Jun. 2020 )/( (Total Assets (Q: Mar. 2020 )+Total Assets (Q: Jun. 2020 ))/ count )
=-254.848/( (481.243+440.931)/ 2 )
=-254.848/461.087
=-55.27 %

Note: The Net Income data used here is four times the quarterly (Jun. 2020) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Intra-Cellular Therapies's Asset Turnover for the quarter that ended in Jun. 2020 is

Asset Turnover
=Revenue (Q: Jun. 2020 )/( (Total Assets (Q: Mar. 2020 )+Total Assets (Q: Jun. 2020 ))/ count )
=1.907/( (481.243+440.931)/ 2 )
=1.907/461.087
=0.00

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Intra-Cellular Therapies Total Assets Related Terms


Intra-Cellular Therapies Total Assets Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)